We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Healthcare Provider and Medical IT Vendor Offer Osteoporosis Assessment

By MedImaging International staff writers
Posted on 27 Sep 2016
Print article
Image: The OneScreen Digital X-Ray Radiogrammetry (DXR) exam of the hand (Photo courtesy of Sectra).
Image: The OneScreen Digital X-Ray Radiogrammetry (DXR) exam of the hand (Photo courtesy of Sectra).
A private care provider in Sweden and a large medical Internet Technology (IT) vendor have join forces to offer preventive bone health testing for people with osteoporosis risk factors.

The screening program is intended to enable preventive measures to be taken, which can reduce or avoid the risk of fractures. Half of all women in Sweden will suffer from a painful bone fracture, usually following menopause, as a result of osteoporosis, which can lead to long-term disabilities.

The OneScreen bone density analysis technology was developed by Sectra (Linköping, Sweden) and is being used by Unilabs (Stockholm, Sweden), a private care provider, to provide preventive bone health testing. The examination is carried out either together with a mammography exam at Unilabs, or separately at a Unilabs radiology clinic. The Sectra OneScreen test uses Digital X-Ray Radiogrammetry (DXR), and is based on a radiology image of the hand. Those individuals who are determined to have a high risk of osteoporosis will receive a further exam and treatment if needed. Studies have shown that the Sectra OneScreen technology can be used for effective osteoporosis care, to identify those patients at risk.

Charlotta Wikström, head of Unilabs’ radiology operation, said, “Thanks to our cooperation with Sectra, we now have the opportunity to offer a complete treatment chain for this serious disease, from initial risk assessment to follow-up and possibly further examinations and treatment.”

Related Links:
Sectra
Unilabs
Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
PACS Workstation
CHILI Web Viewer
New
X-Ray Detector
FDR-D-EVO III
Ultrasound System
Acclarix AX9

Print article
Radcal

Channels

MRI

view channel
Image: Diamond dust offers a potential alternative to the widely used contrast agent gadolinium in MRI (Photo courtesy of Max Planck Institute)

Diamond Dust Could Offer New Contrast Agent Option for Future MRI Scans

Gadolinium, a heavy metal used for over three decades as a contrast agent in medical imaging, enhances the clarity of MRI scans by highlighting affected areas. Despite its utility, gadolinium not only... Read more

Nuclear Medicine

view channel
Image: The new SPECT/CT technique demonstrated impressive biomarker identification (Journal of Nuclear Medicine: doi.org/10.2967/jnumed.123.267189)

New SPECT/CT Technique Could Change Imaging Practices and Increase Patient Access

The development of lead-212 (212Pb)-PSMA–based targeted alpha therapy (TAT) is garnering significant interest in treating patients with metastatic castration-resistant prostate cancer. The imaging of 212Pb,... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.